Literature DB >> 16041692

Airway proteoglycans are differentially altered in fatal asthma.

Marcus de Medeiros Matsushita1, Luiz Fernando Ferraz da Silva, Mario Adriano dos Santos, Sandra Fernezlian, Jasmijn A Schrumpf, Peter Roughley, Pieter S Hiemstra, Paulo Hilário Nascimento Saldiva, Thais Mauad, Marisa Dolhnikoff.   

Abstract

It has been suggested that airway remodelling is responsible for the persistent airway obstruction and decline in lung function observed in some asthmatic patients. The small airways are thought to contribute significantly to this functional impairment. Proteoglycans (PGs) are important components of the extracellular matrix (ECM) in the lungs. Besides controlling biophysical properties of the ECM, they play important roles in the regulation of some cytokines. Increased subepithelial PG deposition in the airways of mild asthmatics has been reported. However, there are no data on the PG content in small airways in asthma. This study has compared the content and distribution of PGs in large and small airways of patients who died of asthma with those in control lungs. Immunohistochemistry and image analysis were used to determine the content of lumican, decorin, biglycan, and versican in large (internal perimeter >6 mm) and small (internal perimeter < or =6 mm) airways of 18 patients who had died of asthma (A) and ten controls (C). The results were expressed as PG area (microm2)/epithelial basement membrane length (microm). The main differences between asthmatics and controls were observed in the small airways. There was a significant decrease in decorin and lumican contents in the external area of small airways in asthmatics (decorin: A = 1.05 +/- 0.27 microm, C = 3.97 +/- 1.17 microm, p = 0.042; lumican: A = 1.97 +/- 0.37 microm, C = 5.66 +/- 0.99 microm, p = 0.002). A significant increase in versican content in the internal area of small and large airways in asthmatics was also observed (small: A = 7.48 +/- 0.84 microm, C = 5.16 +/- 0.61 microm, p = 0.045; large: A = 18.38 +/- 1.94 microm, C = 11.90 +/- 2.86 microm, p = 0.028). The results show that PGs are differentially expressed in the airways of fatal asthma and may contribute to airway remodelling. These data reinforce the importance of the small airways in airway remodelling in asthma. Copyright (c) 2005 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16041692     DOI: 10.1002/path.1818

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  30 in total

Review 1.  Proteoglycans: key regulators of pulmonary inflammation and the innate immune response to lung infection.

Authors:  Sean Gill; Thomas N Wight; Charles W Frevert
Journal:  Anat Rec (Hoboken)       Date:  2010-06       Impact factor: 2.064

Review 2.  Motility, survival, and proliferation.

Authors:  William T Gerthoffer; Dedmer Schaafsma; Pawan Sharma; Saeid Ghavami; Andrew J Halayko
Journal:  Compr Physiol       Date:  2012-01       Impact factor: 9.090

Review 3.  Interplay of extracellular matrix and leukocytes in lung inflammation.

Authors:  Thomas N Wight; Charles W Frevert; Jason S Debley; Stephen R Reeves; William C Parks; Steven F Ziegler
Journal:  Cell Immunol       Date:  2016-12-23       Impact factor: 4.868

Review 4.  Key roles for the small leucine-rich proteoglycans in renal and pulmonary pathophysiology.

Authors:  Madalina V Nastase; Renato V Iozzo; Liliana Schaefer
Journal:  Biochim Biophys Acta       Date:  2014-02-05

5.  Versican Deficiency Significantly Reduces Lung Inflammatory Response Induced by Polyinosine-Polycytidylic Acid Stimulation.

Authors:  Inkyung Kang; Ingrid A Harten; Mary Y Chang; Kathleen R Braun; Alyssa Sheih; Mary P Nivison; Pamela Y Johnson; Gail Workman; Gernot Kaber; Stephen P Evanko; Christina K Chan; Mervyn J Merrilees; Steven F Ziegler; Michael G Kinsella; Charles W Frevert; Thomas N Wight
Journal:  J Biol Chem       Date:  2016-11-28       Impact factor: 5.157

6.  TNF-α-stimulated fibroblasts secrete lumican to promote fibrocyte differentiation.

Authors:  Darrell Pilling; Varsha Vakil; Nehemiah Cox; Richard H Gomer
Journal:  Proc Natl Acad Sci U S A       Date:  2015-09-08       Impact factor: 11.205

Review 7.  Targeting the airway smooth muscle for asthma treatment.

Authors:  Blanca Camoretti-Mercado
Journal:  Transl Res       Date:  2009-07-14       Impact factor: 7.012

Review 8.  Pulmonary fibroblasts, an emerging target for anti-obstructive drugs.

Authors:  Kurt Racké; Susanne Haag; Amit Bahulayan; Mareille Warnken
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-02-13       Impact factor: 3.000

9.  Subepithelial Accumulation of Versican in a Cockroach Antigen-Induced Murine Model of Allergic Asthma.

Authors:  Stephen R Reeves; Gernot Kaber; Alyssa Sheih; Georgiana Cheng; Mark A Aronica; Mervyn J Merrilees; Jason S Debley; Charles W Frevert; Steven F Ziegler; Thomas N Wight
Journal:  J Histochem Cytochem       Date:  2016-04-28       Impact factor: 2.479

10.  What can we learn about airway smooth muscle from the company it keeps?

Authors:  S Siddiqui; F Hollins; C E Brightling
Journal:  Eur Respir J       Date:  2008-07       Impact factor: 16.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.